According to GlaxoSmithKline's latest financial reports the company's current earnings are C$42.35 Billion. In 2024 the company made an earning of C$6.08 Billion a decrease over its 2023 earnings that were of C$10.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.